2nd Pharmacovigilance Audit and Inspection Conference
Website https://go.evvnt.com/325711-0?pid=4800 |
Edit Freely
Category Education
Deadline: March 24, 2019 | Date: March 25, 2019-March 26, 2019
Venue/Country: The Inn at Penn, a Hilton Hotel, U.S.A
Updated: 2019-01-29 16:25:54 (GMT+9)
Call For Papers - CFP
Being adequately prepared for pharmacovigilance audit and inspections is crucial to any bio/pharma company committed to maintaining the highest standards of safety and risk management. As regulators increase PV audits and inspections, placing greater scrutiny on PV quality management systems, it's up to the sponsor to assess internal activities, vendor relationships, commercial partnerships, and others that compromise the PV system.This year, at ExL's 2nd Pharmacovigilance Audit and Inspection Conference will focus on the best practices and strategies for those preparing for their audit and inspection, educating PV professionals on new technologies and innovative methods in pharmacovigilance that are emerging, and how to utilize them to improve organizational performance and reporting.URLs:Tickets: https://go.evvnt.com/325711-1?pid=4800
Brochure: https://go.evvnt.com/325711-3?pid=4800Booking: https://go.evvnt.com/325711-4?pid=4800Prices:Early Bird Pricing - Before February 8, 2019: USD 1895.0,Standard Pricing - After February 8, 2019: USD 2095.0Speakers: Susan Welsh, Chief Safety Officer, CSL BEHRING, Nusrat Sultani, Associate Director, PV Compliance, Global Patient Safety Evaluation (GPSE) Compliance, TAKEDA PHARMACEUTICALS, Julie Miller, Deputy Director, Audit and Inspection Readiness Manager, SANOFI, Claudia Nolte, Director of PV Quality Assurance (PVQA), CSL BEHRING, Fawad Piracha, Risk Management, Pharmacovigilance/Risk Management, REGENERON PHARMACEUTICALS, INC., Marissa Fernandez, Pharmacovigilance Manager, BAXTER HEALTHCARE CORPORATION, Romana Hosain, Head of Risk Management, REGENERON PHARMACEUTICALS, INC., Suzanne Elliott, Director, MRL QA Pharmacovigilance, MERCK, Kevin P. Malobisky, Senior Vice President Regulatory, Quality, and Pharmacovigilance, KARYOPHARM THERAPEUTICS, Jaylaxmi Nalawade, M.D., Associate Director, Pharmacovigilance and REMS, LUPIN SOMERSET, Katie Driscoll-Alberta, Global Head of Quality; R And D, Pharmacovigilance and Commercial Product Samples, ALKERMES, Deepa Arora, Vice President - Pharmacovigilance and Global Head - Drug Safety and Risk Management, LUPIN LIMITED, Richard Wolf, Senior Director Regions and PV Operations, Global Clinical Safety and Pharmacovigilance, CSL BEHRING, Sameer Thapar, Drug Safety and Pharmacovigilance, TEMPLE UNIVERSITY SCHOOL OF PHARMACY Time: 8:00 am to 5:00 pmVenue Details: The Inn at Penn, a Hilton Hotel, 3600 Sansom Street, Philadelphia, 19104, United StatesKeywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.